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Abstract
Background:  In order to elucidate how Hepatitis C Virus (HCV) interacts with polarized
hepatocytes in vivo and how HCV-induced alterations in cellular function contribute to HCV-
associated liver disease, a more physiologically relevant hepatocyte culture model is needed. As
such, NASA-engineered three-dimensional (3-D) rotating wall vessel (RWV) bioreactors were
used in effort to promote differentiation of HCV-permissive Huh7 hepatoma cells.
Results: When cultured in the RWV, Huh7 cells became morphologically and transcriptionally
distinct from more standard Huh7 two-dimensional (2-D) monolayers. Specifically, RWV-cultured
Huh7 cells formed complex, multilayered 3-D aggregates in which Phase I and Phase II xenobiotic
drug metabolism genes, as well as hepatocyte-specific transcripts (HNF4α, Albumin, TTR and
α1AT), were upregulated compared to 2-D cultured Huh7 cells. Immunofluorescence analysis
revealed that these HCV-permissive 3-D cultured Huh7 cells were more polarized than their 2D
counterparts with the expression of HCV receptors, cell adhesion and tight junction markers
(CD81, scavenger receptor class B member 1, claudin-1, occludin, ZO-1, β-Catenin and E-
Cadherin) significantly increased and exhibiting apical, lateral and/or basolateral localization.
Conclusion:  These findings show that when cultured in 3-D, Huh7 cells acquire a more
differentiated hepatocyte-like phenotype. Importantly, we show that these 3D cultures are highly
permissive for HCV infection, thus providing an opportunity to study HCV entry and the effects of
HCV infection on host cell function in a more physiologically relevant cell culture system.
Background
Hepatitis C virus (HCV), a liver tropic positive-stranded
RNA flavivirus, infects ~170 million people worldwide,
causing acute and chronic hepatitis and hepatocellular
carcinoma [1]. However, since its discovery in 1989, a
major obstacle impeding HCV research has been the lack
of robust cell culture and small animal infection models.
Notably significant advancement has been made with the
identification of a genotype 2a HCV consensus clone (Jap-
anese Fulminant Hepatitis, JFH-1) that can replicate and
produce infectious HCV in vitro in the Huh7 human
hepatoma-derived cell line [2-4], allowing for the study of
the entire viral life cycle. This system, however, is limited
in that it makes use of a non-differentiated cell line that
does not recapitulate the cellular conditions encountered
by HCV in vivo [5,6]. In particular, hepatocyte polarity is
likely relevant to HCV entry as growing evidence suggests
interplay between HCV and tight junction (TJ) proteins
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claudin-1 (CLDN1) [7] and occludin [8,9] is essential for
viral uptake. In fact, recent reports surprisingly suggests
that hepatocyte polarity may restricts HCV entry [10,11].
While an inverse relationship between viral entry and
hepatocyte polarity would potentially represent a unique
determinant of HCV entry, to date attempts to dissect this
relationship have been difficult and inconclusive due to
the inability of cell culture grown hepatocyte-derived cell
lines, such as Huh7 cells, to mimic the complex polarized
phenotype of hepatocytes in vivo. To circumvent these
restriction, studies investigating HCV entry into Caco-2
cells [10] and HepG2 cells [11] have been performed as
these cells can polarize to differing degrees in vitro, how-
ever, neither Caco-2 or HepG2 cells supports efficient
HCV infection limiting their utility. As such, a more phys-
iologically relevant hepatocyte tissue culture model is still
needed to assess if cell polarity negatively affects HCV
infection.
The NASA-engineered RWV is a horizontally rotating
cylindrical culture vessel which reduces shear and turbu-
lence associated with conventional stirred bioreactors;
therefore, it simulates aspects of microgravity similar to
the environment encountered during fetal development
[12-14]. In contrast to conventional static tissue culture
systems, cells grown in the RWV are cultured in "sus-
pended animation" where they are continuously free-fall-
ing [12,15]. Thus, while the 2-D environment of plastic
substrates may alter gene expression and prevent cellular
differentiation [12,16-21], the fluid dynamics of the RWV
culture system allow cells to co-localize into three-dimen-
sional (3-D) aggregates, promoting in vivo-like exchange
of growth factors and efficient cell-to-cell interactions [12-
14,20,21]. This in vivo-like environment thus can pro-
mote transformed and primary cell lines to become more
structurally and functionally similar to their in vivo coun-
terparts [13,15,20-24].
In the current study we demonstrate that RWV-cultured
Huh7 cells formed complex, multilayered, 3-D aggregates
that exhibited up-regulation of metabolic and hepatocyte-
specific transcripts as well as increased expression and re-
localization of tight junction, cell adhesion, and polarity
markers. Importantly, these aggregates remained highly
permissive for HCV infection suggesting that hepatic
polarity does not limit HCV entry in 3-D-cultured Huh7
cells. As such, RWV-cultured Huh7 cells may represent a
more appropriate physiologically relevant system for fur-
ther in vitro studies of HCV entry and infection dynamics.
Methods
Cell culture and viruses
Huh7 cells (also known as Huh7/scr cells [25,26] and
Huh7-1 cells [27]) were obtained from Dr. Chisari (The
Scripps Research Institute, La Jolla, CA) [2] and cultured
as previously described [2]. 3-D Huh7 cultures were estab-
lished using previously described techniques [13,14],
with minor modifications. Briefly, 5 × 106 Huh7 cells
were trypisinized, incubated with 250 mg Cytodex-3
microcarrier beads (Sigma, St. Louis, MO) for 30 minutes
at room temperature in a total volume of 30 ml complete
DMEM. Cell-bead complexes were introduced into the
RWV bioreactor (Synthecon, Inc., Houston, TX) at a ratio
of 20 cells/bead, transferred to 37°C, and vessel rotation
was initiated at 20 rotations per minute. Medium was
replenished every 24 h and rotation speed was increased
as aggregates developed to maintain cells in free-falling
suspension.
Protocols for JFH-1 in vitro transcription and HCV RNA
electroporation have been described elsewhere [28]. JFH-
1 cell culture-propagated HCV (HCVcc) viral stocks were
obtained by infection of naïve Huh7-1 cells at a multiplic-
ity of infection (MOI) of 0.01 focus forming units (FFU)/
cell, using medium collected from Huh7 cells on day 18
post transfection with in vitro transcribed pJFH-1 RNA as
previously described [2].
RNA isolation and RTqPCR
Total cellular RNA was isolated by the guanidine thiocy-
anate method using standard protocols [29]. One μg of
RNA was used for cDNA synthesis using TaqMan reverse
transcription reagents (Applied Biosystems, Foster City,
CA), followed by SYBR green real-time quantitative PCR
analysis (RTqPCR) using an Applied Biosystems 7300
real-time thermocycler as previously described [30]. Rela-
tive expression levels of hepatocyte-specific genes and
Phase I and Phase II metabolic genes were assessed using
the primers described in [30] and normalized to β-actin
levels. HCV JFH-1 and GAPDH transcript levels were
determined relative to a standard curve of serially diluted
plasmid containing the JFH-1 cDNA or the human
GAPDH gene, respectively, using primers described in
[28].
Immunofluorescence
Immunofluorescence analysis of aggregates was per-
formed as previously described [14]. Briefly, Huh7 3-D
aggregates were fixed with 4% (v/v) paraformaldehyde
(Sigma, St. Louis, MO), free aldehydes quenched with 50
mM NH4Cl in DPBS for 10 minutes at room temperature
and cells permeabilized with 0.1% Triton-X 100 (Fisher).
In parallel, Huh7 2-D monolayers were seeded in 8-well
chamber slides at 80% confluence and fixed 48 hours post
seeding. 3-D aggregates and 2-D monolayer cells were
stained with antibodies specific for scavenger receptor
class B member 1 (SR-BI) (BD Biosciences, Franklin Lakes,
NJ), CD81 (AbD Serotec, Raleigh, NC), CLDN1 (Abnova,
Taipei, Taiwan), CD26 (Abcam, Cambridge, UK), β-Cat-
enin (Zymed, San Francisco, CA), E-cadherin (Zymed),
zona occludens 1 (ZO-1) (Zymed), Occludin (Zymed) or
HCV E2 (C1 [31]) overnight at 4°C, followed by incuba-Virology Journal 2009, 6:103 http://www.virologyj.com/content/6/1/103
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tion with a 1:1,000 dilution of an appropriate Alexa555-
conjugated secondary antibody (Molecular Probes,
Carlsbad, CA) for 1 h at room temperature. Cell nuclei
were stained by Hoechst dye. Bound antibodies were vis-
ualized via confocal microscopy (630×, Zeiss LSM 510,
Germany). Images were analyzed using Zeiss LSM Alpha
Imager Browser v4.0 software (Zeiss), and brightness and
contrast were adjusted using Adobe®  Photoshop®  (San
Jose, CA). Alternately, 3-D aggregates were embedded in
OCT freezing medium (TissueTek, Fisher) or paraffin, sec-
tioned and stained with Hoechst dye or Hematoxylin and
Eosin (H&E), respectively.
HCV infection kinetics
Huh7 3-D aggregates were infected with JFH-1 HCVcc at
an MOI of 0.01 FFU/cell at day 1, 7 or 14 post RWV seed-
ing by injection of the viral inoculum directly into the
RWV. At indicated times post infection (p.i.), medium
was harvested for titration analysis and RNA was isolated
from ~0.5 ml of aggregates for reverse transcription fol-
lowed by RTqPCR as described above.
Infectivity titration assay
Culture supernatants were serially diluted 10-fold and
used to infect triplicate Huh7 cultures in 96-well plates. At
24 h p.i., cultures were overlayed with complete DMEM
containing 0.4% methylcellulose (Fluka BioChemika,
Switzerland) to give a final concentration of 0.25% meth-
ylcellulose. Seventy-two hours p.i., cells were fixed in 4%
paraformaldehyde (Sigma), and immunohistochemically
stained for HCV E2 using the anti-HCV E2 antibody C1
[31]. Viral titers are expressed as FFU/ml, determined by
the average E2-positive foci number detected at the high-
est HCV-positive dilution.
Results
Establishment of Huh7 3-D Aggregates
To assess the utility of the RWV as a culture method for
Huh7 cells, Huh7 cells were cultured on Cytodex-3 micro-
carrier beads in the RWV for 26 days. Morphological and
cytological examination of cultures demonstrated that
Huh7 cells efficiently adhered to the collagen-coated
microcarrier beads and that these individual beads then
assembled to form 3-D tissue-like aggregates containing
~10–20 beads per aggregate (Fig. 1A). To determine if
these aggregates consisted of multilayered cells, aggregates
were embedded in OCT freezing medium or paraffin, sec-
tioned, stained with either Hoechst stain (Fig. 1B) or H&E
(Fig. 1C–D) and examined by fluorescence or light micro-
scopy, respectively. Panels C and D highlight the multilay-
ered cellular infrastructure of the Huh7 3-D aggregates,
while Hoechst's staining in Panel B illustrates similar
infrastructure and confirms that the aggregates are devoid
of necrotic cores.
Gene Expression within Huh7 3-D Aggregates
One measure of hepatocyte differentiation is up-regula-
tion of expression of transcription factors such as hepato-
cyte nuclear factors (HNF) [32,33], which regulate the
expression of liver secretory proteins [33] such as albumin
[34], alpha-1-antitrypsin (α1AT; [35]), and transthyretin
(TTR; [36]). Likewise, induction of enzymes and trans-
porters involved in Phase I and II xenobiotic metabolism
[37,38], which include cytochrome P450s (CYPs) and
UDP-glucuronosyltransferase (UGTs) enzymes, respec-
tively, is another hallmark of hepatocyte differentiation.
Hence, to determine whether culturing Huh7 cells in the
RWV allows for cellular differentiation at the transcrip-
tional level, expression of hepatocyte-specific genes, CYPs,
and UGTs were analyzed. At indicated times post seeding,
total cellular RNA was extracted from 0.5 ml of 3-D Huh7
aggregates or 2-D Huh7 monolayers grown to confluence,
and relative gene expression was assessed by RTqPCR
analysis. As illustrated in Fig. 2, mRNA levels for the hepa-
tocyte-specific genes and the CYP and UGT enzymes were
significantly induced in 3-D Huh7 aggregates (relative to
2-D Huh7 monolayers) and increased in a time-depend-
ent manner while cultured in the RVW.
Expression and Organization of Cellular Tight Junction 
and Polarity Markers in 3-D Huh7 Aggregates
While the effect of HCV on cell polarity and TJs (and vice-
versa) cannot be accurately studied in 2-D monolayer
Huh7 cultures [10], these interactions are of particular
High-fidelity 3-D Huh7 RWV aggregates Figure 1
High-fidelity 3-D Huh7 RWV aggregates. (A) Phase 
contrast micrograph of Huh7 3-D aggregates cultured in the 
RWV for 14 days (400×). (B) Fluorescence micrograph of 
Hoechst-stained OCT sections of 3-D Huh7 aggregates 
(400×). (C-D) Light micrographs of H&E-stained paraffin sec-
tions of 3-D Huh7 aggregates [200× (C), 600× (D)]. (*) = 100 
μm microcarrier bead.Virology Journal 2009, 6:103 http://www.virologyj.com/content/6/1/103
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interest as TJ proteins are involved in the entry of numer-
ous viruses [39-41] and the TJ proteins CLDN1 [7] and
occludin [8,9] have recently been shown to be involved in
HCV entry. Therefore, we assessed the expression and
organization of the HCV receptors (CD81 and SR-B1), cell
adhesion molecules (E-Cadherin and β-Catenin), cellular
TJ proteins (CLDN1, ZO-1 and Occuldin-1) and the
polarity marker (CD26) in 3-D Huh7 aggregates and their
2-D monolayer counterparts (Fig. 3). The expression of
known HCV receptors and polarity markers were
increased in 3-D Huh7 aggregates as compared 2-D Huh7
monolayers, similar to that observed by Mee et al in polar-
ized Caco-2 cells [10]. This was not a consequence of
increased mRNA levels, as normalized transcript levels for
all markers examined were similar between 3-D and 2-D
Huh7 cultures, as determined by RTqPCR (data not
shown).
As expected, the cell adhesion molecules E-Cadherin and
β-Catenin were membrane localized both in 2-D and 3-D
Huh7 cultures; however, there was a profound decrease in
the accumulation of nuclear β-Catenin-containing com-
plexes in the 3-D Huh7 aggregates. Because atypical
nuclear localization of β-Catenin in transformed cells has
been well documented [42], the loss of this cancer-specific
phenotype in the 3-D cultured Huh7 aggregates is consist-
ent with the loss of cancer-specific markers observed in
other continuous cell lines when cultured in the RWV
[14,23]. Additionally, in contrast to the 2-D Huh7 mon-
olayers, TJ markers localized to apicalateral and/or baso-
lateral planes in the 3-D Huh7 aggregates consistent with
localization patterns observed in primary hepatocytes
[6,43] and normal liver tissues [44]. Finally, CD26, a cell
surface ectopeptidase that localizes to the apical plane of
polarized cells [45], was non-detectable in 2-D Huh7
monolayers, while, apical staining of this marker was
apparent in distinct areas of 3-D Huh7 aggregates (Fig. 3).
Taken together, these data demonstrate that the expres-
sion and distribution of cell adhesion and TJ proteins,
including known HCV entry receptors, is enhanced and
more polarized in 3-D Huh7 cultures than in 2-D monol-
ayers.
HCVcc Infection of Huh7 3-D Aggregates
Because it has been suggested that hepatocyte polarization
is inversely related to the permissiveness of the cell for
HCVcc infection [10,11], we sought to determine if Huh7
3-D cultures were permissive for HCVcc infection. As
such, 3-D Huh7 cultures were inoculated with HCVcc
JFH-1 1, 7, or 14 days post RWV-seeding and culture
supernatant and cellular RNA were harvested at various
time points p.i. for titration of extracellular viral titers and
RTqPCR analysis of viral RNA, respectively. Fig. 4A illus-
trates that HCV not only infected the Huh7 3-D aggre-
gates, but that the kinetics of HCV RNA expansion and
Increased differentiation-specific gene expression in 3-D  Huh7 RWV aggregates Figure 2
Increased differentiation-specific gene expression in 
3-D Huh7 RWV aggregates. At indicated time points 
post seeding, 0.5 ml aliquots of 3-D Huh7 aggregates (~5 × 
104 cells) were removed from the RWV, pelleted at 1400 
RPM for 5 minutes and total RNA extracted. Expression of 
(A) hepatocyte-specific genes, (B) Phase I (CYP) and (C) 
Phase II (UGT) metabolic genes in Huh7 3-D aggregates was 
assessed by RTqPCR. Expression of each transcript, relative 
to 2-D Huh7 monolayer cultures, was determined using the 
 method [50], by normalizing to β-actin expression 
and is graphed as fold induction compared to 2-D monolay-
ers.
2
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infectious virus production increased exponentially to lev-
els comparable to those reported using the robust 2-D
Huh7 system [2,46]. To determine the percentage of cells
expressing HCV proteins, indirect immunofluorescence
analysis of infected 3-D Huh7 aggregates was performed.
Fig. 4B shows that the majority of Huh7 cells were positive
for the HCV E2 glycoprotein and that the entire aggregate
was permissive for HCV infection rather than just the cells
at the periphery, demonstrating that HCV can spread
throughout the aggregates. Importantly, Fig. 4D and 4E
illustrate that aggregates allowed to differentiate in the
RWV for 7 or 14 days were as equally permissive for
HCVcc infection as cells infected 1 day post RWV seeding
(Fig. 4B-C), suggesting that differentiation and polariza-
tion does not negatively affect HCVcc infection in this 3-
D cell culture model.
Discussion
Here we demonstrate that Huh7 cells cultured in RWV
bioreactors form multi-layered tissue-like aggregates that
are phenotypically distinct from traditional Huh7 2-D
monolayers (Fig. 1 and 2). Specifically, the RWV-environ-
ment promoted increases in hepatocyte-specific, as well as
Phase I and II metabolic gene transcripts in 3-D Huh7
Reorganization of HCV receptor, cell adhesion and tight junction protein localization in 3-D Huh7 aggregates Figure 3
Reorganization of HCV receptor, cell adhesion and tight junction protein localization in 3-D Huh7 aggregates. 
Fourteen days post seeding, Huh7 3-D aggregates and parallel Huh7 2-D confluent monolayers were stained with antibodies 
specific for SR-BI, CD81, CLDN1, CD26, β-Catenin, E-cadherin, ZO-1 or Occludin and visualized via confocal microscopy 
(630×, Zeiss LSM 510, Germany). Small vertical panels represent x-z sections (apical = left; basal = right) of larger x-y sections, 
which were compiled by taking 0.5 μm steps through corresponding x-y sections. Red lines indicate the plane from which the z 
section was taken. The scale bar equals 20 μm.Virology Journal 2009, 6:103 http://www.virologyj.com/content/6/1/103
Page 6 of 8
(page number not for citation purposes)
aggregates relative to Huh7 monolayers (Fig. 2). Addition-
ally, we observed increased expression and organization
of cellular HCV receptors, cell adhesion, tight junction
and polarity-specific proteins, and the loss of cancer-asso-
ciated nuclear localization of β-Catenin, in RWV 3-D
Huh7 aggregates as compared to 2-D monolayers (Fig. 3).
These data therefore suggest that the RWV environment
promotes differentiation of Huh7 cells down a more
hepatocyte-like route. Importantly, since these 3-D Huh7
cultures remain highly permissive for HCVcc infection,
this system represents a new in vitro cell culture system for
the study of HCV infection and antiviral drug studies in
more polarized, xenobiotically-competent cells.
Relevant to the study of HCV, expression of the HCV
receptors CD81 and SR-B1 were both diffuse and poorly
organized in 2-D cultured Huh7s cells, while their expres-
sion was increased and localized to apical TJ regions and
basolateral-sinusoidal surfaces in 3-D aggregates. Like-
wise, TJ proteins, which typically localize to the apical sur-
face in polarized hepatocytes [43], were more
concentrated at the apical surface of 3-D Huh7 aggregates
as compared to monolayer cultures. Notably however, the
TJ protein CLDN1, a recently identified HCV receptor [7],
not only localized to TJs, but was also present at both api-
cal and basolateral surfaces in 3-D aggregates. This locali-
zation pattern is in agreement with other studies [47] and
the model proposed by Reynolds et al., describing tight-
junctional (apical) and nonjunctional (basolateral) forms
of CLDN1 in polarized hepatocytes [44]. As suggested by
Mee et al, it may be that these non-junctional pools of
CLDN1 have a direct role in HCV entry [11]. Interestingly,
Battle et al., have demonstrated a correlation between
HNF4α and cell adhesion and TJ molecules expression
and organization [48]. Whether this is also the case in the
3-D Huh7 aggregates, which have increased HNF4α
expression (Fig. 2A) remains to be determined. Nonethe-
less, the ability of 3-D cultured Huh7 cells to better organ-
ize cell adhesion and TJ proteins is a phenotype consistent
with other RWV-cultured cell types [14,21,23]. As such,
RWV-cultured Huh7 cells provide an appropriate model
for investigating HCV entry, particularly the interaction,
organization, and stoichiometry of HCV receptors and TJ
proteins. Additional analyses to determine the extent of
differentiation and polarization of 3-D Huh7 aggregates is
still warranted and a focus of ongoing studies.
To date, attempts to study HCV in polarized cells have
been limited to colorectal adenocarcinoma Caco-2 cells
[10] or HepG2 cells [11], neither of which support robust
HCVcc infection. Although an inverse relationship
between cell polarization and HCV entry into polarized
Caco-2 [10] and HepG2 [11] cells has been observed no
such phenotype was observed in 3-D Huh7 aggregates.
Specifically, 3-D Huh7 aggregates, infected at various
Robust HCVcc infection in 3-D Huh7 RWV cultures Figure 4
Robust HCVcc infection in 3-D Huh7 RWV cultures. 
(A) Huh7 3-D aggregates were infected with HCVcc JFH-1 at 
an MOI of 0.01 FFU/cell 1 day post seeding in the RWV. Cul-
ture supernatant and intracellular RNA were collected at the 
indicated times p.i. Normalized intracellular HCV RNA copy 
numbers, displayed as HCV RNA copies/μg total cellular 
RNA (line), were determined by RTqPCR. Infectivity titers, 
expressed as FFU/ml (bars), were determined by immunohis-
tochemical analysis of 10-fold serially diluted culture superna-
tants on naïve Huh7 cells. (B) Indirect immunofluorescence 
analysis of HCV E2 expression in HCV-infected 3-D Huh7 
aggregates 14 days p.i. Additional 3-D Huh7 cultures were 
infected on day 1 (C), 7 (D) or 14 (E) post seeding in the 
RWV. Aggregates were fixed 10 days p.i. and stained with a 
human anti-E2 antibody (C1) and anti-human-Alexa 555 sec-
ondary antibody. Images were captured via confocal micros-
copy (630×, Zeiss LSM 510, Germany) and Zeiss LSM Alpha 
Imager Browser v4.0 software (Zeiss). Image brightness and 
contrast were adjusted using Adobe®Photoshop® (San Jose, 
CA). (*) = 100 μm microcarrier bead. Small vertical panels 
represent x-z sections of larger x-y sections, which were 
compiled by taking 0.5 μm steps through corresponding x-y 
sections. Red lines indicate the plane from which the z sec-
tion was taken. The scale bar equals 20 μm.Virology Journal 2009, 6:103 http://www.virologyj.com/content/6/1/103
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stages of differentiation (e.g. day 1, 7 or 14 post seeding),
were equally permissive for HCVcc infection (Fig. 4B–E).
Furthermore, 3-D aggregates treated with PMA, a known
disruptor of TJ formation [49], were no more permissive
for HCV infection as compared to untreated parallel
aggregates (data not shown), suggesting that the TJ barri-
ers formed in 3-D Huh7 aggregates are not inhibitory for
HCVcc infection.
Conclusion
Growing evidence suggests interplay between TJ protein
expression, localization and function and HCV infection.
Although, the current HCV infectious 2-D Huh7 cell cul-
ture system does not amend itself well to elucidating these
dynamic relationships, the highly HCV-permissive 3-D
Huh7 cell culture system described herein more closely
mimics the differentiated and polarized state of hepato-
cytes. As such the RWV 3-D Huh7 cell culture system
should prove useful for understanding the dynamic rela-
tionship between HCV and TJ protein expression as well
as elucidating how HCV interacts with and disrupts key
aspects of hepatocyte physiology.
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